1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aspartic acid in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (aspartic acid) | Trials (aspartic acid) | Recent Studies (post-2010) (aspartic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 23,005 | 417 | 4,018 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | aspartic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.638 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 90.1265 | |
| Excitatory amino acid transporter 2 | Homo sapiens (human) | 11 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.638 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domańska-Janik, K; Zabøocka, B | 1 |
| Martin, D; Nadler, JV; Peterson, CL; Thompson, MA | 1 |
| Le Gouill, C; Parent, JL; Rola-Pleszczynski, M; Stanková, J | 1 |
| Escher, E; Gouill, CL; Parent, JL; Rola-Pleszczynski, M; Staková, J | 1 |
| Hauptmann, S; Kirkpatrick, CJ; Klosterhalfen, B; Küpper, W; Offner, FA; Tietze, L; Töns, C | 1 |
| Li, Y; Liang, L; Tian, X; Zhong, L; Zhou, J | 1 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aspartic acid
| Article | Year |
|---|---|
PAF antagonist, BN52021, inhibits [3H]D-aspartate release after ischaemia in vitro.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aspartic Acid; Brain Ischemia; Diterpenes; Enzyme Activation; Ginkgolides; Hippocampus; In Vitro Techniques; Isoquinolines; Lactones; Phorbol 12,13-Dibutyrate; Piperazines; Platelet Activating Factor; Potassium; Protein Kinase C; Rats; Rats, Wistar; Tritium | 1994 |
Modulation of glutamate and aspartate release from slices of hippocampal area CA1 by inhibitors of arachidonic acid metabolism.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arginine; Aspartic Acid; Female; Flavanones; Flavonoids; gamma-Aminobutyric Acid; Glutamates; Hippocampus; In Vitro Techniques; Indoles; Indomethacin; Masoprocol; omega-N-Methylarginine; Platelet Activating Factor; Potassium; Prostaglandin-Endoperoxide Synthases; Quinacrine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Taurine | 1995 |
Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Azepines; Binding Sites; Binding, Competitive; Cell Line; Chlorocebus aethiops; CHO Cells; Conserved Sequence; Cricetinae; GTP-Binding Proteins; Inositol Phosphates; Kinetics; Mutagenesis, Site-Directed; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Point Mutation; Protein Conformation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Transfection; Triazoles | 1996 |
Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis.
Topics: Amino Acid Sequence; Animals; Asparagine; Aspartic Acid; Azepines; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Inositol Phosphates; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Conformation; Proto-Oncogene Proteins c-myc; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Transfection; Triazoles | 1996 |
Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspartic Acid; Blood Pressure; Cardiac Output; Disease Models, Animal; Endotoxemia; Gene Expression; HSP70 Heat-Shock Proteins; Inflammation Mediators; Interleukin-1; Interleukin-6; Kidney; Lipopolysaccharides; Metallothionein; Platelet Activating Factor; Pulmonary Artery; Recurrence; Swine; Thromboxane B2; Tumor Necrosis Factor-alpha; Zinc | 1996 |
Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo.
Topics: Adult; Aspartic Acid; beta-Thromboglobulin; Case-Control Studies; Female; Glycerol; Humans; Lipidomics; Lysophosphatidylcholines; Male; Metabolome; Phosphorylcholine; Platelet Activating Factor; Platelet Factor 4; Succinic Acid; Vitiligo; Young Adult | 2019 |